Lucid Diagnostics Inc.

NASDAQ:LUCD

0.945 (USD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Assets:
Current Assets:
Cash & Cash Equivalents 18.89622.47453.6560.1110.1560.018
Short Term Investments 01.3311.1160.1180.1180
Cash and Short Term Investments 18.89622.47453.6560.1110.1560.018
Net Receivables 0.0450.0170.2000
Inventory 0.2780.1110.4930.83400
Other Current Assets 3.1321.7542.9541.3290.2340
Total Current Assets 22.07324.35657.3031.440.3910.018
Non-Current Assets:
Property, Plant & Equipment, Net 2.6413.60.971000
Goodwill 000000
Intangible Assets 1.4243.4450000
Goodwill and Intangible Assets 1.4243.4450000
Long Term Investments 000000
Tax Assets 000000
Other Non-Current Assets 1.1321.1080.7250.7550.6430
Total Non-Current Assets 5.1978.1531.6960.7550.6430
Total Assets 27.2732.50958.9992.1951.0340.018
Liabilities & Equity:
Current Liabilities:
Account Payables 1.1461.0561.492.0580.7990.497
Short Term Debt 15.0560.9620000
Tax Payables 000000
Deferred Revenue 000000
Other Current Liabilities 13.186.4072.7713.6565.5440.583
Total Current Liabilities 29.3828.4254.2615.7136.3431.08
Non-Current Liabilities:
Long Term Debt 0.1991.0370000
Deferred Revenue Non-Current 000000
Deferred Tax Liabilities Non-Current 000000
Other Non-Current Liabilities -002,770000
Total Non-Current Liabilities 0.1991.0372,770000
Total Liabilities 29.5819.4624.2615.7136.3431.08
Equity:
Preferred Stock 18.62500000
Common Stock 0.0420.0410.0350.0140.0140.01
Retained Earnings -150.741-98.075-41.904-13.826-5.546-1.126
Accumulated Other Comprehensive Income/Loss -18,62500000
Other Total Stockholders Equity 18,754.763121.08196.6080.2940.2230.053
Total Shareholders Equity -2.31123.04754.739-13.518-5.309-1.063
Total Equity -2.31123.04754.739-13.518-5.309-1.063
Total Liabilities & Shareholders Equity 27.2732.50958.9992.1951.0340.018